NCT04164199 2026-04-14Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced MalignanciesBeOne MedicinesPhase 3 Active not recruiting404 enrolled
NCT07235293 2026-04-09A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.Kahr MedicalPhase 2 Recruiting90 enrolled